What is Alectinib?

Category: Prescription Drugs

Most popular types: Alecensa


Alectinib is a generic drug commonly used to treat non-small cell lung cancer. This treatment blocks anaplastic lymphoma kinase activity.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 5
Mild 1
None 1

Commonly reported side effects and conditions associated with Alectinib

Side effect Patients
Fatigue 2
Fluid retention (edema) 2
Mental fatigue or exhaustion 2
Blood pressure fluctuates 1
Bowel problems 1
Leg pain with exertion 1

Show all 8 reported side effects


Based on patients currently taking Alectinib

Dosage Patients
600 mg twice daily 5
450 mg twice daily 1

Why patients stopped taking Alectinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
Other 1
See 1 patient who's stopped taking Alectinib


Currently taking Alectinib

Duration Patients
6 months - 1 year 5
1 - 2 years 1

Stopped taking Alectinib

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 8
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 2
Not at all hard to take 6
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 4

What people switch to and from

Patients started taking Alectinib after stopping:

Treatment Patients
Crizotinib (Xalkori) 6
Ceritinib (Zykadia) 1

Patients stopped taking Alectinib and switched to:

Treatment Patients
Crizotinib (Xalkori) 1
Last updated:
There are no evaluations for Alectinib.